FDA NDC Directory · JSON-LD · Markdown

CLONAZEPAM

NDC 62332-367 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211033
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsCLONAZEPAM (1 mg/1)
Marketing started20190701
Package count1

External sources

Source: openFDA. Public-domain (CC0).